U.K. drug maker agrees to buy Transkaryotic

Article Abstract:

Shire Pharmaceuticals Group PLC of the United Kingdom is to acquire Transkaryotic Therapies Inc. of the United States for $1.6 billion. Chief Executive Officer of Transkaryotic Therapies Inc., Michael Astrue has resigned in apparent disagreement with the acquisition. Transkaryotic Therapies Inc., a biotechnology company, shares are up 16 percent to $35.21 on the Nasdaq Stock Exchange.

Author: Bulkeley, William M., Berton, Elena
Commodity & service prices, Securities issued, listed, Security brokers and dealers, Securities & Commodities Services, Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Prices and rates, Securities industry, Securities, Company securities, Company pricing policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hedge Funds vex a Shire takeover of Transkaryotic

Article Abstract:

Shire Pharmaceuticals Group PLC of the United Kingdom is to acquire Transkaryotic Therapies Inc. of the United States for $1.6 billion. One third of Transkaryotic Therapies Inc.'s shareholders want their shares appraised, which could raise the price of the acquisition for Shire Pharmaceuticals Group PLC.

Author: Berton, Elena
Financial management, Investor relations

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Marconi will link ipsaris with Easynet in stock deal

Article Abstract:

Marconi PLC will merge its ipsaris Ltd. subsidiary with Easynet Group PLC. The newly-merged entity will provide broadband services.

Author: Berton, Elena
Telecommunications, Telegraph & other communications, Telephone Communication, Planning, Internet service providers, Telecommunications industry, Broadband transmission, Broadband, Telent PLC, Ipsaris, Easynet Group PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Company acquisition/merger, Shire Pharmaceuticals Group PLC, Transkaryotic Therapies Inc.
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.